Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Journal of the American Board of Family Practice
|
September 23, 2000
Impact of an electronic medical record system on community-based primary care practices
K A Wager, F W Lee, A W White, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 1997
Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR
H N Bramson, D Hermann, K W Batchelor, et al.
Pharmaceutical Biotechnology
|
October 7, 1998
Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase
S V Frye, H N Bramson, D J Hermann, et al.
Optics Express
|
March 19, 2009
A liquid-filled tunable double-focus microlens
H B Yu, G Y Zhou, F K Chau, et al.
Pharmaceutical Biotechnology
|
October 7, 1998
Discovery of bioavailable inhibitors of secretory phospholipase A2
S G Blanchard, R C Andrews, P J Brown, et al.
The Journal of Experimental Medicine
|
September 28, 1999
Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus
S W Wong, E P Bergquam, R M Swanson, et al.
The Joint Commission Journal on Quality Improvement
|
July 1, 1997
The computer-based patient record as a CQI tool in a family medicine center
S M Ornstein, R G Jenkins, F W Lee, et al.
Chemico-Biological Interactions
|
November 4, 2004
Testing paradigm for prediction of development-limiting barriers and human drug toxicity
V G Sasseville, J H Lane, V J Kadambi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans
E J Mroszczak, F W Lee, D Combs, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
August 15, 1998
Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice
M B Zemel, J W Moore, N Moustaid, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Journal of the American Board of Family Practice
|
September 23, 2000
Impact of an electronic medical record system on community-based primary care practices
K A Wager, F W Lee, A W White, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 1997
Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR
H N Bramson, D Hermann, K W Batchelor, et al.
Pharmaceutical Biotechnology
|
October 7, 1998
Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase
S V Frye, H N Bramson, D J Hermann, et al.
Optics Express
|
March 19, 2009
A liquid-filled tunable double-focus microlens
H B Yu, G Y Zhou, F K Chau, et al.
Pharmaceutical Biotechnology
|
October 7, 1998
Discovery of bioavailable inhibitors of secretory phospholipase A2
S G Blanchard, R C Andrews, P J Brown, et al.
The Journal of Experimental Medicine
|
September 28, 1999
Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus
S W Wong, E P Bergquam, R M Swanson, et al.
The Joint Commission Journal on Quality Improvement
|
July 1, 1997
The computer-based patient record as a CQI tool in a family medicine center
S M Ornstein, R G Jenkins, F W Lee, et al.
Chemico-Biological Interactions
|
November 4, 2004
Testing paradigm for prediction of development-limiting barriers and human drug toxicity
V G Sasseville, J H Lane, V J Kadambi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans
E J Mroszczak, F W Lee, D Combs, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
August 15, 1998
Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice
M B Zemel, J W Moore, N Moustaid, et al.
Page
of 5